Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moxley Holdings is a private early-stage venture capital firm rather than an operating biotech, pharma, or healthcare company. Public profiles describe it as investing in data-enabled businesses across sectors including insurance, energy, and biotechnology. The firm appears to have been active as an investor in companies such as Pie Insurance and in Insurtech Gateway financing. Available evidence also indicates that Moxley Holdings later operated under the name Echelon Capital. Because it is an investment firm, it does not appear to have an internal therapeutic pipeline, drug programs, or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moxley Holdings.